Abstract：Objective To investigate the feasibility of transfection of early endothelial progenitor cells (EPCs) in peripheral blood of patients with acute myocardial infarction (AMI) in vitro using pvax1-mediated nitric oxide synthase (eNOS) gene. Methods From December 2017 to June 2018, 30 cases of AMI patients admitted to Shaanxi Provincial People′s Hospital due to heart disease and diagnosed by coronary angiography were selected. The Ficoll density gradient centrifugation method was used to isolate mononuclear cells in the peripheral blood of patients with fasting veins and induce them to culture into EPCs for identification and purification of pvax-enos plasmids. EPCs were divided into three groups: eNOS transfection group, cationic polymer JetPEITM was used to transfect eNOS gene into EPCs in vitro. After transfection for 24 h, nitric oxide (NO) content in EPCs was detected by nitrate reductase method, and the ability of eNOS and vascular endothelial growth factor (VEGF) secretion by EPCs was detected by ELISA and Western blot. The proliferation of EPCs was detected by Wst-1 method, and the migration and adhesion of EPCs in each group were detected by Transwell chamber. Empty plasmid transfection group, only pVAX empty plasmid was transfected into EPCs. Control group, no transfection of EPCs. Results Pvax-enos gene was successfully transfected into early EPCs of AMI patients, and 24 h after transfection, the content of NO was significantly increased compared with the blank plasmid transfection group and the control group (P ＜ 0.01), The expression of eNOS was significantly increased (P ＜ 0.01), and the ability to secrete VEGF was significantly increased (P ＜ 0.01). The ability of proliferation, migration and adhesion of EPCs was significantly increased (P ＜ 0.01), and there was no significant difference between the empty plasmid transfection group and the control group (P ＞ 0.05). Conclusion Cationic polymer JetPEITM can successfully mediate the effective transfection of pvax-enos into early EPCs in AMI patients, and effectively enhance the proliferation, migration, adhesion and secretion of EPCs, which lays a foundation for the improvement of myocardial ischemia in AMI patients by autologous EPCs transplantation.
黄晓燕1 王沙2 沈鑫3 孙晶莹1 董向辉4 靳占奎4 宋宝国2 梁导艳1 徐翠香5. pVAX-eNOS转染急性心肌梗死患者早期内皮祖细胞及对其活性的影响[J]. 中国医药导报, 2019, 16(11): 9-13.
HUANG Xiaoyan1 WANG Sha2 SHEN Xin3 SUN Jingying1 DONG Xianghui4 JIN Zhankui4 SONG Baoguo2 LIANG Daoyan1 XU Cuixiang5. Effect of pVAX-eNOS transfection on the early endothelial progenitor cells from the patients with acute myocardial infarction. 中国医药导报, 2019, 16(11): 9-13.
[1] Simard T，Jung RG，Motazedian P，et al. Progenitor cells for arterial repair：incremental advancements towards therapeutic reality [J]. Stem Cells Int，2017（2017）：8270498.
[2] Sun YY，Bai WW，Wang B，et al. Period 2 is essential to maintainearly endothelial progenitor cell function in vitro and angiogenesis after myocardial infarction in mice [J]. J Cell Mol Med，2014，18（5）907-918.
[3] Ashara T，Murohara T，Sullivan A，et al. Isolation of putative progenitor endothelial cells for angiogenesis [J]. Science，1997，275（5302）：964-967.
[4] Santas-Alvarez M，Rodino-Janeiro BK，Paradela-Dobarro B，et al. Endothelial progenitor cells mobilisation after percutaneous coronary intervention：a pilot study [J]. Br J Biomed Sci，2016，73（4）：193-200.
[5] 耿海华，刘继东.冠心病患者循环内皮祖细胞与冠脉病变轻重程度的临床分析[J].细胞与分子免疫学杂志，2010， 26（12）：1250-1251.
[6] Yadlapati M，Biguetti C，Cavalla F，et al. Characterization of a vascμlar endothelial growth factor-loaded bioresorbable delivery system for pμlp regeneration [J]. J Endod，2017， 43（1）：77-83.
[7] 夏鑫，吴明华.血管相关内皮祖细胞标志物研究[J].脑与神经疾病杂志，2018，26（1）：65-66.
[8] Sen S，McDonald SP，Coates FT，et al. Endothelial progenitor cells：novelbiomarker and promising cell therapy for cardiovascular disease [J]. Clin Sci（Lond），2011，120（7）：263-283.
[9] Annex BH. Therapeutic angiogenesis for critical limb ischaemia [J]. Nat Rev Cardiol，2013，10，（7）：387-396.
[10] Aicher A，Brenner W，Zuhayra M，et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling [J]. Circμlation，2003，29（107）：2134-2139.
[11] Bakogiannis C，Tousoulis D，Androulakis E，et al. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes [J]. Curr Med Chem，2012，19（16）：2597-2604.
[12] Kotlinowski J，Dulak J，Józkowicz A. Type 2 diabetes mellitus impairs endothelial progenitor cells function [J]. PostepyBiochem，2013，59（3）：257-266.
[13] Dimagno MJ，Williams JA，Hao Y，et al. Endothelial nitric oxide sythase is protective in the initiation of caerulein-induced acute pancreatitis in mice [J]. Am J Physiol Gastrointest Liver Physiol，2004，287（1）：G80-G87.
[14] Wang XM，Wang Y，WANG Ying，et al. Construction，identification and immunoreactivity of mycobacterium tuberculosis DNA vaccine pVAX1/ESAT-6 plasmid [J]. J South Med Univ，2013，33（7）：945-950.
[15] Monika GJ，Edyta P，Bogus?覥aw M，et al. Effects of Angiotensin-Converting Enzyme Inhibition on Circulating Endothelial Progenitor Cells in Patients with Acute Ischemic Stroke [J]. Stem Cells International，2018，2018：2827580.
[16] Nishant PS，Ahmed A，Haitham A，et al. Cardiac rehabilitation：current review of the literature and its Role in Patients with Heart Failure [J]. Curr Treat Options Cardio Med，2018，20（2）：12.
[17] Hill JM，Zalos G，Halcox JPG，et al. Circulating endothelial p rogenitor cells，vascular function，and cardiovascular risk [J]. N Engl J Med，2003，348（7）：593-600.
[18] Heeschen C，Lehman R，Honold J，et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease [J]. Circulation，2004，109（13）：1615-1622.
[19] Yan J，Tie G，Park B，et al. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice： roles of endothelial nitric oxide synthase and endothelial progenitor cells [J]. J Vasc Surg，2009，50（6）：1412-1422.
[20] Deng Y，Wang J，He G，et al. Mobilization of endothelial progenitor cell in patients with patients with acute ischemic stroke [J]. Neurol Sci，2018，39（3）：437-443.
[21] Sheng ZL，Yao YY，Li YF，et al. Transplantation of bradykinin-preconditioned human endothelial progenitor cells improves cardiac function via enhanced Akt/eNOS phosphorylation and angiogenesis [J]. Am J Transl Res，2015， 7（7）：1214-1226.
[22] Go?覥?諭b JM，Paczkowska E，Machaliński B，et al. Effects of angiotensin-Converting enzyme inhibition on circμlating endothelial progenitor cells in patients with acute ischenic stroke [J]. Stem CellI Int，2018：2827580.
[23] Kawasaki. K，Smith RS，Hsieh CM，et al. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis [J]. Mol Cell Biol，2003，23（16）：5726-5737.
[24] Reyes M，Dudek A，Jahagirdar B，et al. Origin of endothelial progenitors in human postnatal bone marrow [J]. J Clin Invest，2002，109（3）：337-346.
[25] Wang S，Chen Z，Tang X，et al. Transplantation of vascular endothelial growth factor 165 transfected endothelial progenitor cells for the treatment of limb ischemia [J]. Mol Med Rep，2015，12（4）：4967-4974.
2019, Vol. 16 
京公网安备 11010502046598号